NxStage Medical Quick Ratio 2006-2018 | NXTM

Historical quick ratio values for NxStage Medical (NXTM) over the last 10 years.
NxStage Medical Quick Ratio Historical Data
Date Current Assets - Inventory Current Liabilities Quick Ratio
2018-09-30 $0.16B $0.06B 2.69
2018-06-30 $0.12B $0.05B 2.36
2018-03-31 $0.11B $0.05B 2.39
2017-12-31 $0.10B $0.05B 2.20
2017-09-30 $0.10B $0.05B 2.19
2017-06-30 $0.10B $0.05B 2.24
2017-03-31 $0.10B $0.05B 2.15
2016-12-31 $0.10B $0.05B 1.99
2016-09-30 $0.10B $0.05B 2.01
2016-06-30 $0.09B $0.05B 2.10
2016-03-31 $0.09B $0.04B 2.14
2015-12-31 $0.09B $0.04B 2.12
2015-09-30 $0.09B $0.04B 2.01
2015-06-30 $0.08B $0.04B 1.98
2015-03-31 $0.08B $0.04B 1.87
2014-12-31 $0.08B $0.05B 1.87
2014-09-30 $0.09B $0.05B 1.85
2014-06-30 $0.10B $0.05B 2.14
2014-03-31 $0.11B $0.05B 2.37
2013-12-31 $0.11B $0.04B 2.88
2013-09-30 $0.11B $0.04B 2.95
2013-06-30 $0.12B $0.04B 2.80
2013-03-31 $0.13B $0.04B 2.99
2012-12-31 $0.13B $0.04B 3.26
2012-09-30 $0.12B $0.04B 3.57
2012-06-30 $0.12B $0.03B 3.77
2012-03-31 $0.12B $0.03B 3.81
2011-12-31 $0.12B $0.03B 3.95
2011-09-30 $0.12B $0.04B 3.44
2011-06-30 $0.12B $0.04B 3.23
2011-03-31 $0.12B $0.03B 3.45
2010-12-31 $0.12B $0.04B 3.31
2010-09-30 $0.04B $0.03B 1.31
2010-06-30 $0.04B $0.03B 1.20
2010-03-31 $0.04B $0.03B 1.16
2009-12-31 $0.04B $0.03B 1.27
2009-09-30 $0.04B $0.03B 1.28
2009-06-30 $0.04B $0.02B 1.54
2009-03-31 $0.03B $0.04B 0.87
2008-12-31 $0.04B $0.04B 1.09
2008-09-30 $0.04B $0.04B 1.11
2008-06-30 $0.04B $0.04B 0.99
2008-03-31 $0.03B $0.04B 0.75
2007-12-31 $0.05B $0.04B 1.31
2007-09-30 $0.04B $0.02B 2.15
2007-06-30 $0.06B $0.02B 3.35
2007-03-31 $0.08B $0.02B 4.76
2006-12-31 $0.07B $0.01B 5.24
2006-09-30 $0.08B $0.01B 7.16
2006-06-30 $0.09B $0.01B 9.59
2006-03-31 $0.05B $0.01B 5.20
2005-12-31 $0.06B $0.01B 8.89
2005-09-30 $0.01B $0.01B 2.09
2005-06-30 $0.00B $0.00B 0.00
2005-03-31 $0.00B $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $1.954B $0.394B
NxStage Medical, Inc. is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative systems for the treatment of end-stage renal disease, or ESRD, and acute kidney failure.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $132.164B 26.13
Medtronic (MDT) Ireland $123.923B 18.53
Stryker (SYK) United States $69.625B 25.56
Boston Scientific (BSX) United States $55.366B 27.03
Baxter (BAX) United States $39.075B 24.08
Zimmer Biomet Holdings (ZBH) United States $25.222B 16.18
Smith & Nephew SNATS (SNN) United Kingdom $16.659B 0.00
ResMed (RMD) United States $14.394B 27.30
Canopy Growth (CGC) Canada $11.042B 0.00
Bio-Rad Laboratories (BIO) United States $8.100B 51.79
Aurora Cannabis (ACB) Canada $7.040B 50.36
Hill-Rom Holdings (HRC) United States $6.974B 21.57
Perrigo (PRGO) Ireland $6.650B 10.09
Insulet (PODD) United States $5.226B 0.00
ICU Medical (ICUI) United States $5.190B 28.91
GW Pharmaceuticals (GWPH) United Kingdom $4.539B 0.00
Haemonetics (HAE) United States $4.489B 39.82
Agios Pharmaceuticals (AGIO) United States $3.462B 0.00
Hutchison China MediTech (HCM) China $3.417B 0.00
Neogen (NEOG) United States $3.281B 50.39
NuVasive (NUVA) United States $3.013B 28.03
National Vision Holdings (EYE) United States $2.624B 50.75
Quidel (QDEL) United States $2.574B 23.28
Aphria (APHA) $2.402B 106.67
AtriCure (ATRC) United States $1.279B 0.00
Phibro Animal Health (PAHC) United States $1.231B 17.70
VAREX IMAGING (VREX) United States $1.198B 23.45
Cardiovascular Systems (CSII) United States $1.170B 840.00
MacroGenics (MGNX) United States $0.923B 0.00
Cerus (CERS) United States $0.878B 0.00
PetIQ (PETQ) United States $0.837B 21.68
Surmodics (SRDX) United States $0.766B 111.39
Evolus (EOLS) United States $0.747B 0.00
NanoString Technologies (NSTG) United States $0.719B 0.00
Lantheus Holdings (LNTH) United States $0.713B 22.07
Meridian Bioscience (VIVO) United States $0.704B 20.98
OraSure Technologies (OSUR) United States $0.703B 31.03
Omeros (OMER) United States $0.688B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.625B 20.05
Quanterix (QTRX) United States $0.505B 0.00
LeMaitre Vascular (LMAT) United States $0.492B 24.18
Owens & Minor (OMI) United States $0.479B 5.42
TG Therapeutics (TGTX) United States $0.395B 0.00
Insys Therapeutics (INSY) United States $0.368B 0.00
Utah Medical Products (UTMD) United States $0.334B 21.65
BioLife Solutions (BLFS) United States $0.299B 404.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.293B 0.00
Bovie Medical (APYX) United States $0.279B 0.00
Vapotherm (VAPO) United States $0.276B 0.00
Cytosorbents (CTSO) United States $0.262B 0.00
Rockwell Medical (RMTI) United States $0.242B 0.00
Zynex (ZYXI) United States $0.165B 15.97
Surface Oncology (SURF) United States $0.150B 0.00
Fonar (FONR) United States $0.143B 7.65
Chembio Diagnostics (CEMI) United States $0.119B 0.00
Chimerix (CMRX) United States $0.101B 0.00
United-Guardian (UG) United States $0.091B 18.98
Female Health (VERU) United States $0.084B 0.00
CAS Medical Systems (CASM) United States $0.070B 0.00
Trinity Biotech (TRIB) Ireland $0.063B 17.33
Conatus Pharmaceuticals (CNAT) United States $0.062B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Neurotrope (NTRP) United States $0.034B 0.00
Senestech (SNES) United States $0.021B 0.00
Capricor Therapeutics (CAPR) United States $0.013B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.013B 0.00
Akers Biosciences Inc (AKER) United States $0.011B 0.00
Valeritas Holdings (VLRX) United States $0.010B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.007B 13.57